Amplexd Therapeutics, Inc., a biotech company focused on accessible treatments for HPV-induced Cervical Intraepithelial Neoplasia (CIN), has announced significant progress…
Memo Therapeutics AG, a biotech company based in Switzerland, has successfully raised an additional CHF 20 million in an extension…
Oncternal Therapeutics, a leading biopharmaceutical company, is set to release its first-quarter financial results on May 9, 2024, after the…